Longitudinal gut microbiota composition of South African and Nigerian infants in relation to tetanus vaccine responses/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-6-25

Curated date: 2024/03/18

Curator: Aishat

Revision editor(s): WikiWorks, Scholastica, Victoria, Aishat, Ifeanyisam, Taofeecoh

Subjects

Location of subjects
South Africa
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
HIV infection [X]Human immunodeficiency virus disease,[X]Human immunodeficiency virus disease (disorder),[X]Unspecified human immunodeficiency virus [HIV] disease,[X]Unspecified human immunodeficiency virus [HIV] disease (disorder),HIV - Human immunodeficiency virus infection,HIV INFECT,HIV Infection,HIV infection,HIV Infections,HIV infectious disease,HTLV III INFECT,HTLV III Infections,HTLV III LAV INFECT,HTLV III LAV Infections,HTLV WIII INFECTIONS,HTLV WIII LAV INFECTIONS,HTLV-III Infection,HTLV-III Infections,HTLV-III-LAV Infection,HTLV-III-LAV Infections,HUMAN IMMUNO VIRUS DIS,human immunodeficiency virus,Human immunodeficiency virus [HIV] disease,HUMAN IMMUNOdeficiency VIRUS [HIV] INFECTION,Human immunodeficiency virus caused disease or disorder,Human immunodeficiency virus disease,Human immunodeficiency virus disease (disorder),Human immunodeficiency virus disease or disorder,Human immunodeficiency virus infection,Human immunodeficiency virus infection (disorder),Human immunodeficiency virus infection, NOS,Human immunodeficiency virus infectious disease,human immunodeficiency virus infectious disease,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T,T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN,T Lymphotropic Virus Type III Infections, Human,T-Lymphotropic Virus Type III Infections, Human,Unspecified human immunodeficiency virus [HIV] disease (disorder),hIV infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Infants who are HIV unexposed and uninfected (iHUU) at week 1
Group 1 name Corresponds to the case (exposed) group for case-control studies
Infants who are HIV exposed but uninfected (iHEU) at week 1
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Infants at 1 week of age born to mothers from South Africa who have HIV but are not themselves infected with HIV
Group 0 sample size Number of subjects in the control (unexposed) group
21
Group 1 sample size Number of subjects in the case (exposed) group
61

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-25

Curated date: 2024/03/18

Curator: Aishat

Revision editor(s): Aishat, Scholastica, WikiWorks

Source: Table 2

Description: Differentially abundant ASVs (adj P < 0.05) among iHEU (infants who are HIV exposed but uninfected) relative to iHUU (infants who are HIV unexposed and uninfected) at 1 week of age in South Africa

Abundance in Group 1: increased abundance in Infants who are HIV exposed but uninfected (iHEU) at week 1

NCBI Quality ControlLinks
Klebsiella variicola
unclassified Sutterella
unclassified Holdemanella
Parabacteroides merdae
unclassified Catenibacterium
Blautia obeum
unclassified Senegalimassilia
Bifidobacterium breve
Klebsiella quasipneumoniae
unclassified Parolsenella
unclassified Blautia
[Ruminococcus] torques
Collinsella aerofaciens
unclassified Subdoligranulum
Phocaeicola vulgatus
Klebsiella pneumoniae
unclassified Megamonas
Romboutsia ilealis
unclassified Faecalibacterium
Fusobacterium mortiferum
Enterococcus faecium
Parabacteroides distasonis

Revision editor(s): Aishat, Scholastica, WikiWorks

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-6-25

Curated date: 2024/03/18

Curator: Aishat

Revision editor(s): Aishat, Scholastica, WikiWorks

Source: Table 2

Description: Differentially abundant ASVs (adj P < 0.05) among iHEU (infants who are HIV exposed but uninfected) relative to iHUU (infants who are HIV unexposed and uninfected) at 1 week of age in South Africa

Abundance in Group 1: decreased abundance in Infants who are HIV exposed but uninfected (iHEU) at week 1

NCBI Quality ControlLinks
unclassified Actinomyces
Parabacteroides distasonis

Revision editor(s): Aishat, Scholastica, WikiWorks